Form4insider filings, from the source

SEC Form 4 · accession 0001567619-18-007956

Kura Oncology, Inc. · KURA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Dec 11, 2018
Accepted (ET)
Dec 13, 2018 · 6:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001422143

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockDec 11, 2018P15,321$13.9089A4,195,512D
Common StockDec 13, 2018P25,217$13.89A4,220,729D

Table II — derivative securities

No Table II lines on this filing.